Table S2. Correlation between CYP2B6*9 (G516T) variant and the clinical outcome following cyclophosphamide chemotherapy.

Outcome	Wild-type genotype (GG)	Variant genotypes (GT + TT)	p-value
	n = 41	n = 53
Response	34 (83%)	20 (37.5%)	<0.001*
Non-response	6 (14.5%)	31 (58.5%)	<0.001*
Toxic–Death	1 (2.5%)	2 (4%)	= 0.71

Note: Chi-square and Fischer Exact tests were applied. *: Statistically significant test (if p < 0.05).